Who are Oral Polio Vaccine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Stamaril, Sanofi Pasteur, varicella-5, Bacille Calmette Guerin (BCG), Measles, mumps, rubella vaccine, Measles Vaccine (MV), SKYVaricella®.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/oral-polio-vaccine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Oral Polio Vaccine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oral Polio Vaccine (Oral Polio Vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology / Infectious Disease.

marketed Live attenuated vaccine Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Oral Polio Vaccine (Oral Polio Vaccine) — International Centre for Diarrhoeal Disease Research, Bangladesh. Oral Polio Vaccine stimulates the immune system to produce antibodies against poliovirus by delivering live attenuated (weakened) poliovirus strains orally.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Oral Polio Vaccine TARGET	Oral Polio Vaccine	International Centre for Diarrhoeal Disease Research, Bangladesh	marketed	Live attenuated vaccine
Stamaril, Sanofi Pasteur	Stamaril, Sanofi Pasteur	Epicentre	marketed	Live attenuated vaccine	Yellow fever virus (17D strain)
varicella-5	varicella-5	Changchun Keygen Biological Products Co., Ltd.	marketed	Live attenuated vaccine	Varicella-zoster virus
Bacille Calmette Guerin (BCG)	Bacille Calmette Guerin (BCG)	Bandim Health Project	marketed	Live attenuated vaccine
Measles, mumps, rubella vaccine	Measles, mumps, rubella vaccine	PATH	marketed	Live attenuated vaccine
Measles Vaccine (MV)	Measles Vaccine (MV)	PATH	marketed	Live attenuated vaccine
SKYVaricella®	SKYVaricella®	SK Bioscience Co., Ltd.	marketed	Live attenuated vaccine	Varicella-zoster virus (VZV)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

GlaxoSmithKline · 19 drugs in this class
Merck Sharp & Dohme LLC · 11 drugs in this class
Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
PATH · 5 drugs in this class
Sanofi · 5 drugs in this class
Bandim Health Project · 5 drugs in this class
Centers for Disease Control and Prevention · 3 drugs in this class
International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
Beijing Center for Disease Control and Prevention · 2 drugs in this class
Aga Khan University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oral Polio Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/oral-polio-vaccine. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab